UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000021303
Receipt No. R000024520
Scientific Title Feasibility of Cytoreductive Prostatectomy in Men Newly Diagnosed with Metastatic Prostate Cancer
Date of disclosure of the study information 2016/04/01
Last modified on 2020/08/20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Feasibility of Cytoreductive Prostatectomy in Men Newly Diagnosed with Metastatic Prostate Cancer
Acronym Feasibility of Cytoreductive Prostatectomy
Scientific Title Feasibility of Cytoreductive Prostatectomy in Men Newly Diagnosed with Metastatic Prostate Cancer
Scientific Title:Acronym Feasibility of Cytoreductive Prostatectomy
Region
Japan Asia(except Japan) North America

Condition
Condition metastatic prostate cancer
Classification by specialty
Urology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To determine the safety and feasibility of cytoreductive prostatectomy in men with newly diagnosed clinical T1-3N1M0 or T1-3N0M1a-b prostate cancer.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Phase I,II

Assessment
Primary outcomes the rate of major peri-operative complications (Clavien-Dindo grade
III or higher, please see appendix A) that occur within 90 days after cytoreductive
prostatectomy.
Key secondary outcomes 1) time to PSA nadir and 2) time to rising PSA while on standard systemic therapy.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Patients deemed to have cT3 or less will be offered the Robotic Assisted Radical Prostatectomy (RARP).
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male
Key inclusion criteria 1 Histologically proven adenocarcinoma of the prostate.
2 Evidence of lymph node or bone metastasis by MRI/CT, bone scan, or biopsy
(N1Mx or NxM1).
3 Give informed consent.
4 Clinical stage T3 or less (pelvic MRI or CT scan shows no rectal and ureteral
invasion).
5 Must be male and 18 years or older
6 Cleared by the primary medical doctor for surgery.
7 ECOG Performance Status of 0 or 1.
Key exclusion criteria 1 Males under the age of 20.
2 Refuses to give informed consent.
3 Refuses or is unable to have pelvic MRI or CT scan.
4 Clinical stage T4 (pelvic MRI shows rectal and/or ureteral invasion).
5 Deemed a poor surgical risk per primary medical doctor.
6 Known spinal cord compression or brain or liver metastasis or any other visceral
metastases.
7 DVT/PE in the past 6 months
Target sample size 10

Research contact person
Name of lead principal investigator
1st name Shigeo
Middle name
Last name Horie
Organization Juntendo University Hospital
Division name Dept. of Urology
Zip code 1138431
Address 3-1-3 Hongo Bunkyo-ku, Tokyo, Japan
TEL +81-3-3813-3111
Email shorie@juntendo.ac.jp

Public contact
Name of contact person
1st name Masayoshi
Middle name
Last name Nagata
Organization Juntendo University Hospital
Division name Dept. of Urology
Zip code 1138431
Address 3-1-3 Hongo Bunkyo-ku, Tokyo, Japan
TEL +81-3-5802-1227
Homepage URL
Email m-nagata@juntendo.ac.jp

Sponsor
Institute Juntendo University, Graduate School of Medicine
Institute
Department

Funding Source
Organization health insurance
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor Rutgers Cancer Institute of New Jersey, University of Pennsylvania (Philadelphia, PA), Temple University (Philadelphia, PA), City of Hope (Duarte, CA), University of California at Irvine (Orange, CA),
Swedish Medical Center (Seattle, WA), Seoul National University Bundang Hospital (Seoul, Korea)
Name of secondary funder(s)

IRB Contact (For public release)
Organization Juntendo University Ethics Committee
Address 3-1-3 Hongo Bunkyo-ku, Tokyo, Japan
Tel 03-3813-3111
Email jun-rinri@juntendo.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions Rutgers Cancer Institute of New Jersey, University of Pennsylvania (Philadelphia, PA), Temple University (Philadelphia, PA), City of Hope (Duarte, CA), University of California at Irvine (Orange, CA), Swedish Medical Center (Seattle, WA), Seoul National University Bundang Hospital (Seoul, Korea)

Other administrative information
Date of disclosure of the study information
2016 Year 04 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 01 Month 20 Day
Date of IRB
2020 Year 01 Month 31 Day
Anticipated trial start date
2016 Year 04 Month 01 Day
Last follow-up date
2018 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2016 Year 03 Month 02 Day
Last modified on
2020 Year 08 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024520

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.